I think there were some results released in Denmark this morning in relation to trials with Ozempic which apparently delivered some outstanding results with respect to Kidney disease. It will certainly raise questions on the due diligence on the 16.7B spent on the Vifor buy.
- Forums
- Charts
- Is Aegros a genuine Threat to CSL?
I think there were some results released in Denmark this morning...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$295.21 |
Change
0.050(0.02%) |
Mkt cap ! $142.6B |
Open | High | Low | Value | Volume |
$296.30 | $298.20 | $295.00 | $229.6M | 780.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 248 | $295.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$295.21 | 42 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4 | 295.000 |
1 | 46 | 294.500 |
2 | 6 | 293.600 |
1 | 136 | 292.760 |
1 | 50 | 291.750 |
Price($) | Vol. | No. |
---|---|---|
295.780 | 60 | 1 |
295.980 | 67 | 1 |
296.000 | 200 | 1 |
296.250 | 202 | 1 |
296.620 | 123 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online